Navigation Links
Philippe Généreux, MD, presented with 2012 TCT Young Investigator Award
Date:10/26/2012

MIAMI, FL OCTOBER 26, 2012 Philippe Gnreux, MD was presented the TCT 2012 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The award is given each year to a promising researcher in the field of interventional cardiovascular medicine. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiology.

The award honors the memory of Thomas J. Linnemeier, MD, the former chief of the Indiana Heart Institute, senior vice president of New Ventures, and chief medical officer of Vascular Intervention at Guidant Corp. The purpose of the award, which is accompanied by a $10,000 grant, is to encourage the recipient to maintain a continued commitment and dedication to both patient care and academic research.

An outstanding young academician and a prolific writer, Dr. Philippe Gnreux is a practicing Interventional Cardiologist at Hpital du Sacr-Coeur de Montral. Dr. Gnreux also serves as the Director of the Angiographic Core Laboratory at the CRF Clinical Trials Center where he leads the lab's coronary, peripheral, and structural imaging analyses and services. He received his medical degree from the Universit de Montral, Qubec, Canada, and is currently pursuing a PhD at Erasmus University in Rotterdam, The Netherlands. His research interests include coronary risk stratification/Syntax score, coronary physiology and imaging, percutaneous aortic valve replacement, transradial intervention, drug-eluting stent innovation, and medical simulation.

The winner was selected by Drs. Sheldon Goldberg, Howard C. Herrmann, John W. Hirshfeld Jr. and Robert L. Wilensky from Philadelphia. Gregg W. Stone, MD and Howard C. Hermann, MD jointly presented the award. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Herrmann is Professor of Medicine and the Director of Interventional Cardiology and Cardiac Catheterization Labs at the Hospital of the University of Pennsylvania.

"Dr. Gnreux's tireless commitment to the dual tracks of cardiovascular research and patient care have established him as a rising star in the field, and he is well on his way to becoming a future leader in interventional cardiology," said Drs. Stone and Herrmann.

"We are extremely proud to honor Dr. Philippe Gnreux with the TCT 2012 Young Investigator Award for his exceptional academic achievements and superb clinical skills, as well as his dedication and passion for the field," Martin B. Leon, MD added. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Drs. Leon and Stone both serve as Co-Directors of the Medical Research and Education Division at CRF, and direct the annual TCT scientific sessions.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Results of the XIMA trial presented at TCT 2012
2. Barry D. Rutherford, M.D. presented with Master Clinical Operator Award at TCT 2012
3. Renu Virmani, M.D. presented with 2012 TCT Career Achievement Award
4. Results of the AIDA STEMI MRI sub-study presented at TCT 2012
5. Results of the PC trial presented at TCT 2012
6. Results of the POSEIDON trial presented at TCT 2012
7. 1-year results of ADAPT-DES presented at TCT 2012
8. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
9. New clinical guidelines for managing hypothyroid disease presented in Thyroid Journal
10. Research presented at TCT 2012 will have significant impact on interventional cardiology
11. Typical IBD patients not represented in research studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, ... officially formed a distribution partnership with Byers Scientific & Manufacturing , a ... , Through the agreement, OMI Industries formulated a special version of Ecosorb® for ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical economic ... the Frank Hawkins Kenan Institute of Private Enterprise at the University ... makers identified concrete solutions at the “What’s Next, America?” conference at the Kenan ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: January 23, ... Kleyne, the nation’s foremost water advocate and host of the nationally syndicated The ... Voice America, once again welcomed one of her favorite guests and colleagues, Dr. ...
(Date:1/24/2017)... ... ... “Speaking With God’s Voice”: a resolute and spirited call for anointed preaching ... A. Miraglia, a born-again believer, who spent his years teaching high school and Sunday-school, ... “There is little doubt that God Himself prepared me for this study, and God’s ...
(Date:1/24/2017)... ... , ... “The Octagon of Spiritual Balances”: a guide for the Christian ... of published author, Pastor Bernard J. Weathers, pastor of Word of Faith Ministries, in ... education and a master degree in theology. , ““The Octagon of Spiritual Balances” exposes ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Implantable Medical Devices ... over the next decade to reach approximately $54.28 billion by 2025 ... witnessing include 3D medical printing is expected to develop and find ...
(Date:1/24/2017)... , and GAITHERSBURG, Md. , Jan. ... XON ), a leader in the engineering and industrialization of ... the planet, today announced that it has entered into a ... GNVC ), a clinical-stage company and pioneer in the ... intends to integrate and expand upon GenVec,s expertise in adenoviral ...
(Date:1/24/2017)... 24, 2017   QR Pharma , Inc., ... novel therapies for the treatment of Alzheimer,s, Parkinson,s ... of four world-class key opinion leaders to its ... QR Pharma,s previous roster of impressive advisors in ... support the development of the breakthrough mechanism of ...
Breaking Medicine Technology: